The COVID-19 surge in Indonesia: what we learned and what to expect

Eric Daniel Tenda; Moses Mazmur Asaf; Ariel Pradipta; Meutia Ayuputeri Kumaheri; Anindya Pradipta Susanto

doi:10.1183/20734735.0146-2021

The COVID-19 surge in Indonesia: what we learned and what to expect

Breathe (Sheff). 2021 Dec;17(4):210146. doi: 10.1183/20734735.0146-2021.

Authors

Eric Daniel Tenda^{1

2

3}, Moses Mazmur Asaf^{1

3}, Ariel Pradipta^{2

4}, Meutia Ayuputeri Kumaheri⁴, Anindya Pradipta Susanto^{2

4}

Affiliations

¹ Division of Respirology and Critical Illness, Dept of Internal Medicine, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
² Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
³ Contributed equally as co-first authors.
⁴ Genomik Solidaritas Indonesia (GSI) Lab, Jakarta, Indonesia.

Abstract

Through the implementation of a test and trace system, disciplined public health measures, the acceleration of vaccinations, and a genome surveillance programme, LMICs such as Indonesia can prevent future outbreaks and survive the COVID-19 pandemic. https://bit.ly/3JBBSie.

Publication types

Editorial